Jacobs Levy Equity Management’s ChemoCentryx CCXI Stock Holding History
Bought
Maintained
Sold
Other funds holding CCXI
Jacobs Levy Equity Management's CCXI Position: Q4 2019 in Review
Jacobs Levy Equity Management sold out of ChemoCentryx (CCXI) in Q4 2019, closing a stake of 24,500 shares — an estimated $166K sold.
Jacobs Levy Equity Management first reported a position in CCXI in Q4 2014 and held it in 15 quarters. The position peaked at $1.18M in Q2 2017. 126 funds tracked by Wall St. Rank hold CCXI as of Q4 2019.
- Jacobs Levy Equity Management reported no remaining ChemoCentryx position as of Q4 2019 after selling out during the quarter.
- Jacobs Levy Equity Management sold 24,500 ChemoCentryx shares in Q4 2019, an estimated $166K.
- Jacobs Levy Equity Management first reported a position in ChemoCentryx in Q4 2014 and held it in 15 quarters.
- Jacobs Levy Equity Management's ChemoCentryx position peaked at $1.18M in Q2 2017.
- 126 funds tracked by Wall St. Rank held ChemoCentryx as of Q4 2019.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2019, filed 14 Feb 2020.